Ergomed Plc

Ergomed (ERGO)

[ADVERT]
Company name:Ergomed Plc
EPIC:ERGOTrading Currency:GBX
Market Sector:AS50ISIN:GB00BN7ZCY67
Market Segment:AMSMShare Type:DE
WWW Address:http://ergomedgroup.com/Description:ORD 1P
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Offer Open High Low Volume
 1,395.00 images.advfn.com/imagesnew/2/gb/up 5.0 [0.36] 1,380.00 1,395.00 1,365.00 1,415.00 1,360.00 14,048
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 681.22 48.83 -0.24 20.00 - 69.75 - 1,565.00 - 685.00

Ergomed Key Figures

(at previous day's close)
Market Cap.681.22m
Shares In Issue48.83m
Prev. Close1,390.00
PE Ratio69.75 
Dividend Yield-%
EPS - basic20.00p
Dividend PS-p
Dividend Cover- 
Cash Flow PS36.96p
Return On Equity (ROE)18.31%
Operating Margin14.62%
PEG Factor1.05 
EPS Growth Rate66.67%
Dividends PS Growth Rate-%
Net Debt20.49m
Gross Gearing42.75%
Quick Assets51.67m
Net Working Capital18.06m
Intangibles / Fixed Assets95.72%
Turnover PS176.91p
Pre-Tax Profit PS25.86p
Retained Profit PS19.83p
Cash PS38.90p
Net Cash PS-29.93p
Net Tangible Asset Value PS *28.52p
Net Asset Value PS108.26p
Spread15.00 (1.08%) 

Ergomed Balance Sheet

L^ERGO:Liabilities+EQL^ERGO:Assets

Share Price Performance

Sample Period HighLow
1 week1,545.001,355.00
4 weeks1,565.001,185.00
12 weeks1,565.001,095.00
1 year1,565.00685.00

Share Price Chart (5 years)

Ergomed Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week1,545.00-150.00-9.711,355.000.031,462.53
4 weeks1,230.00165.0013.411,185.000.111,318.04
12 weeks1,250.00145.0011.601,095.000.071,257.31
26 weeks1,225.00170.0013.881,060.000.081,226.90
1 year695.00700.00100.72685.000.141,023.00
3 years167.001,228.00735.33142.500.14586.93
5 years120.001,275.001,062.50118.000.11498.62

Ergomed Key Management Ratios

Ergomed Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio72.67 
PE Ratio69.75 
Tobin's Q Ratio 9.12 
Tobin's Q Ratio (excl. intangibles)15.28 
Dividend Yield-%
Market-to-Book Ratio12.89 
Price-to-Pre-Tax Profit PS53.95 
Price-to-Retained Profit PS70.36 
Price-to-Cash Flow PS37.74 
Price-to-Sales PS7.89 
Price-to-Net Tangible Asset Value PS48.91 
Price-to-Cash PS35.86 
Net Working Capital PS36.98 
Price Pct to Working Capital PS37.73%
Earnings Yield1.43%
Average PE67.60 
Years in average3 
PE to PE average103.18%

Ergomed Financial Ratios

(Leverage Ratios)
Debt Ratio10.00%
Debt-to-Equity Ratio0.11 
Debt-to-Equity Ratio (excl. Intgbl)0.42 
Debt-to-Equity Market Value0.01 
Net Gearing22.19%
Net Gearing (excl. Intangibles)38.36%
Gross Gearing42.75%
Gross Gearing (excl. Intangibles)73.92%
Gearing Under 1 Year36.40%
Gearing Under 1 Year (excl. Intgbl)62.93%
Assets/Equity1.75 
Cash/Equity35.93 
(Liquidity Ratios)
Net Working Capital to Total Assets19.55%
Current Ratio1.54 
Quick Ratio (Acid Test)1.54 
Liquidity Ratio0.57 
Cash & Equiv/Current Assets36.76%
(Solvency Ratios)
Enterprise Value668.10m
CFO/Sales0.21 
CFO/Attributable Profit1.86 
CFO/Assets0.20 
CFO/Debt0.46 
Total Debt/Equity Market Value0.06 
Total Debt/Sales0.46 
Total Debt/Pre-Tax Profit3.13 
Total Debt39.48m
Total Debt/Net Current Assets2.19%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth72.75%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs3 
Beta (60-Mnth)Beta (36-Mnth)
-0.23760.0152

Ergomed Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)21.50%
Return On Assets (ROA)12.96%
Net Profit Margin11.21%
Assets Turnover1.16 
Return On Equity (ROE)18.31%
Return On Investment (ROI)19.38%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio21.59%
Net Income Of Revenues11.21%
(Asset Utilisation Multiples)
Shareholders Equity Turnover1.93 
Fixed Assets Turnover2.74 
Current Assets Turnover2.00 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales0.86 
Debtors-to-Sales30.69%
Debt Collection Period112.03Days

Ergomed Dividends

Sorry No Data Available

Ergomed Fundamentals

 31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)
turnover47.62100.00%54.11100.00%68.26100.00%86.39100.00%m
pre tax profit-4.45-9.34%-10.77-19.90%4.997.30%12.6314.62%m
attributable profit-4.50-9.46%-8.98-16.60%5.578.16%9.6811.21%m
retained profit-4.50-9.46%-8.98-16.60%5.578.16%9.6811.21%m
eps - basic (p)-11.00 -20.00 12.00 20.00 
eps - diluted (p)-11.00 -20.00 11.50 19.20 
dividends per share- - - - 

Ergomed Balance Sheet

 31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)
L^ERGO:Liabilities+EQL^ERGO:AssetsL^ERGO:Liabilities+EQL^ERGO:AssetsL^ERGO:Liabilities+EQL^ERGO:AssetsL^ERGO:Liabilities+EQL^ERGO:Assets
 31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)
ASSETS
fixed assets fixed assets1.081.74%1.342.87%1.111.95%1.741.89%m
intangibles intangibles35.5057.34%17.4037.13%21.3137.36%38.9442.16%m
fixed investments fixed investments0.751.22%2.074.41%--%--%m
current assets - other current assets - other0.500.81%--%--%--%m
stocks stocks--%--%--%--%m
debtors debtors20.8633.70%20.8744.53%20.3635.69%32.6835.38%m
cash & securities cash & securities3.225.20%5.1911.07%14.2625.00%18.9920.57%m
TOTAL61.91100%46.86100%57.03100%92.35100%m
LIABILITIES
creditors - short creditors - short13.8622.39%17.1936.67%15.8627.81%33.6136.40%m
creditors - long creditors - long13.2121.33%1.312.80%4.357.63%5.876.36%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL27.0743.72%18.5039.48%20.2135.44%39.4842.75%m
EQUITY
ord cap, reserves ord cap, reserves34.8456.28%28.3660.52%36.8264.56%52.8757.25%m
prefs, minorities prefs, minorities--%--%--%--%m
TOTAL34.8456.28%28.3660.52%36.8264.56%52.8757.25%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Ergomed Cash Flow Statement

31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)
Operating CF0.031.0411.7918.05m
Pre-Financing CF-3.89-1.698.965.27m
Retained CF-1.212.088.714.80m

Ergomed Brokers

Broker infomation is not available for this class of stock.
ADVFN Advertorial
Your Recent History
LSE
ERGO
Ergomed
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210916 15:19:11